Han Gon Choi

1.3k total citations
38 papers, 1.0k citations indexed

About

Han Gon Choi is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Han Gon Choi has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 10 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Han Gon Choi's work include Drug Solubulity and Delivery Systems (7 papers), Advanced Drug Delivery Systems (6 papers) and Crystallization and Solubility Studies (4 papers). Han Gon Choi is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Advanced Drug Delivery Systems (6 papers) and Crystallization and Solubility Studies (4 papers). Han Gon Choi collaborates with scholars based in South Korea, Pakistan and China. Han Gon Choi's co-authors include Chul Soon Yong, Jung‐Ae Kim, Jong Soo Woo, Chul Soon Yong, Jong Oh Kim, Madhuri Newa, Krishna Hari Bhandari, Mi‐Kyoung Kwak, Fakhar ud Din and Won Seok Lyoo and has published in prestigious journals such as Scientific Reports, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Han Gon Choi

38 papers receiving 997 citations

Peers

Han Gon Choi
Yogendra Nayak India
Vieri Piazzini Italy
Kalvatala Sudhakar India
Rongfeng Hu China
Jiaxin Pi China
Ubonthip Nimmannit Thailand
Feng Shi China
Dhanalekshmi Unnikrishnan Meenakshi India
Usama A. Fahmy Saudi Arabia
Yogendra Nayak India
Han Gon Choi
Citations per year, relative to Han Gon Choi Han Gon Choi (= 1×) peers Yogendra Nayak

Countries citing papers authored by Han Gon Choi

Since Specialization
Citations

This map shows the geographic impact of Han Gon Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Gon Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Gon Choi more than expected).

Fields of papers citing papers by Han Gon Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Gon Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Gon Choi. The network helps show where Han Gon Choi may publish in the future.

Co-authorship network of co-authors of Han Gon Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Han Gon Choi. A scholar is included among the top collaborators of Han Gon Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Gon Choi. Han Gon Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jamshaid, Humzah, Fakhar ud Din, Saif Ullah Khan, et al.. (2022). Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation. Biomaterials Advances. 145. 213266–213266. 17 indexed citations
2.
Din, Fakhar ud, Saif Ullah Khan, Zakir Ali, et al.. (2022). Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects. Life Sciences. 311(Pt B). 121198–121198. 29 indexed citations
3.
Jamshaid, Humzah, Fakhar ud Din, Maimoona Malik, et al.. (2022). A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice. Scientific Reports. 12(1). 14244–14244. 26 indexed citations
4.
Yan, Yi-Dong, Nirmal Marasini, Jong Oh Kim, et al.. (2011). Effect of dose and dosage interval on the oral bioavailability of docetaxel in combination with a curcumin self-emulsifying drug delivery system (SEDDS). European Journal of Drug Metabolism and Pharmacokinetics. 37(3). 217–224. 18 indexed citations
5.
Yan, Yi-Dong, Dong Won Lee, Jung Sun Kim, et al.. (2011). Evaluation of physicochemical properties, skin permeation and accumulation profiles of salicylic acid amide prodrugs as sunscreen agent. International Journal of Pharmaceutics. 419(1-2). 154–160. 17 indexed citations
6.
Thapa, Dinesh, et al.. (2011). Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status. Archives of Pharmacal Research. 34(2). 323–330. 14 indexed citations
7.
Thapa, Dinesh, Jong Suk Lee, Yong Rok Lee, et al.. (2010). Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis. European Journal of Pharmacology. 650(1). 64–71. 34 indexed citations
8.
Kim, Dae Hwan, et al.. (2010). Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. International Journal of Pharmaceutics. 399(1-2). 116–120. 53 indexed citations
9.
Kim, Kyoung Jin, Mi‐Kyoung Kwak, Han Gon Choi, et al.. (2009). Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-κB activation. European Journal of Pharmacology. 622(1-3). 52–57. 44 indexed citations
10.
Thapa, Dinesh, Jong Suk Lee, Young-Joon Park, et al.. (2009). Inhibitory effects of clotrimazole on TNF-α-induced adhesion molecule expression and angiogenesis. Archives of Pharmacal Research. 32(4). 593–603. 22 indexed citations
11.
Park, Jae‐Hyun, Sang‐Cheol Chi, Won Seok Lee, et al.. (2009). Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process. Archives of Pharmacal Research. 32(1). 139–148. 26 indexed citations
12.
Park, Byung Chul, Su‐Young Park, Jong-Suk Lee, et al.. (2008). The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling. Vascular Pharmacology. 50(3-4). 123–131. 22 indexed citations
13.
Newa, Madhuri, Krishna Hari Bhandari, Jung‐Hoon Sung, et al.. (2008). Enhanced Dissolution of Ibuprofen Using Solid Dispersion with Polyethylene Glycol 20000. Drug Development and Industrial Pharmacy. 34(10). 1013–1021. 27 indexed citations
14.
15.
Park, Byung Chul, Seunghee Park, Su‐Young Park, et al.. (2008). Chloroquine-induced nitric oxide increase and cell death is dependent on cellular GSH depletion in A172 human glioblastoma cells. Toxicology Letters. 178(1). 52–60. 32 indexed citations
16.
Newa, Madhuri, Krishna Hari Bhandari, Dong Hoon Oh, et al.. (2008). Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Archives of Pharmacal Research. 31(11). 1497–1507. 86 indexed citations
17.
18.
Thapa, Dinesh, Jong Suk Lee, Su‐Young Park, et al.. (2008). Clotrimazole Ameliorates Intestinal Inflammation and Abnormal Angiogenesis by Inhibiting Interleukin-8 Expression through a Nuclear Factor-κB-Dependent Manner. Journal of Pharmacology and Experimental Therapeutics. 327(2). 353–364. 38 indexed citations
19.
Park, Byung Chul, Dinesh Thapa, Yoonseok Lee, et al.. (2007). 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP. European Journal of Pharmacology. 567(3). 193–197. 18 indexed citations
20.
Shanmugam, Srinivasan, Eung Seok Lee, Tae Cheon Jeong, et al.. (2007). The effect of 1-furan-2-yl-3-pyridine-2-yl-propenone on pharmacokinetic parameters of warfarin. Archives of Pharmacal Research. 30(7). 898–904. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yogendra Nayak Breakdown of academic impact, for papers by Vieri Piazzini Breakdown of academic impact, for papers by Kalvatala Sudhakar Breakdown of academic impact, for papers by Rongfeng Hu Breakdown of academic impact, for papers by Jiaxin Pi Breakdown of academic impact, for papers by Ubonthip Nimmannit Breakdown of academic impact, for papers by Feng Shi Breakdown of academic impact, for papers by Dhanalekshmi Unnikrishnan Meenakshi Breakdown of academic impact, for papers by Usama A. Fahmy
Rankless by CCL
2026